Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Six months after COVID-19, most patients still had autoantibodies.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Common gene patterns may cause skin autoimmune diseases.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.